•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.The little chips that could: How Impinj has survived 26 years in a market that's ‘just getting going'
Impinj to Announce Second-Quarter 2026 Financial Results
Director Sells 33,000 Impinj Shares Worth $4.6 Million
Director Sells 45,000 Impinj Shares Worth $6.4 Million
Intel vs. Impinj: Which Technology Stock Is a Better Buy in 2026?
Insiders Are Selling These 3 Stocks—Should Investors Be Concerned?
New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myel
Large Impinj Investor Trims Position by $11.3 Million
Imagion Biosystems' IND Application for MagSense® Phase 2 Clinical Trial Clears FDA Review
Impinj (PI) Just Reclaimed the 200-Day Moving Average
Impinj to Participate in Evercore Global TMT Conference
Impinj (PI) Just Flashed Golden Cross Signal: Do You Buy?
Is Impinj Inc (PI) Overvalued After 6.8% Rally? GF Value Says Overvalued
Impinj Inc (PI) Stock Down 4.7% but Still Overvalued -- GF Score: 73/100
This Beaten-Down Chip Stock Just Did Something It Hasn't Done in a Year. Time to Buy?
How Impinj Stock Jumped 20.5% Today
This Chip Maker's Stock Is Soaring After Earnings. Analysts See 20% More Upside.
Impinj, Inc. (PI) Q1 2026 Earnings Call Transcript
Impinj (PI) Tops Q1 Earnings and Revenue Estimates
Impinj Reports First Quarter 2026 Financial Results